Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Epilepsy × Fentanyl × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 21 Neoplasms 19 Colonic Neoplasms 7 Agnosia 6 Cancer Pain 5 Breast Neoplasms 5 Breakthrough Pain 5 Rectal Neoplasms 4 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Pain, Postoperative 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Chronic Pain 3 Sarcoma 2 Pleural Effusion, Malignant 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Carcinoma, Hepatocellular 2 Burns 2 Brain Neoplasms 2 Anemia, Sickle Cell 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Anticonvulsants 2 perampanel 1 clevidipine 1 brivaracetam 1 Vigabatrin 1 Topotecan 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Sulfasalazine 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Paclitaxel 1 Nitrous Oxide 1 Midazolam 1 Memantine 1 Medical Marijuana 1 Lidocaine 1 Levetiracetam 1 Ketamine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Gabapentin 1 Fluid Therapy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡